KLBF logo

PT Kalbe Farma Tbk. Stock Price

IDX:KLBF Community·Rp44.6t Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 30 Fair Values set on narratives written by author

KLBF Share Price Performance

Rp985.00
-255.00 (-20.56%)
Rp985.00
-255.00 (-20.56%)
Price Rp985.00

KLBF Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Flawless balance sheet with solid track record and pays a dividend.

0 Risks
5 Rewards

PT Kalbe Farma Tbk. Key Details

Rp35.3t

Revenue

Rp21.5t

Cost of Revenue

Rp13.8t

Gross Profit

Rp10.1t

Other Expenses

Rp3.7t

Earnings

Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
n/a
80.93
39.05%
10.38%
1.0%
View Full Analysis

About KLBF

Founded
1966
Employees
12835
CEO
Bernadette Ruth Setiady
WebsiteView website
www.kalbe.co.id

PT Kalbe Farma Tbk., together with its subsidiaries, engages in the development, manufacture, and trading of pharmaceutical products in Indonesia. It operates through Prescription Pharmaceuticals; Consumer Health; Nutritionals; and Distribution and Logistic segments. The company provides prescription/ethical; consumer health; nutritionals; distribution and logistics; health services; medical devices; biopharma; animal health; international business, and E-health products. In addition, the company provides health screening services; operates as an agent and representative for biotechnology products; distributes consumer products, medical equipment, cosmetics, and other trading products; and trades in medical and laboratory equipment and supplies, raw materials for pharmaceutical products, and consumable products for hemodialysis therapy, as well as offers advertising services. The company was incorporated in 1966 and is headquartered in Jakarta, Indonesia.

Recent KLBF News & Updates

Recent updates

No updates

PT Kalbe Farma Tbk. Competitors